The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term outcome of breast cancer patients diagnosed ≤40 years according to breast cancer subtype in the absence of adjuvant systemic therapy: The PARADIGM initiative.
 
Gwen Dackus
No Relationships to Disclose
 
Natalie D ter Hoeve
No Relationships to Disclose
 
Mark Opdam
No Relationships to Disclose
 
Willem Vreuls
No Relationships to Disclose
 
Esther A Koop
No Relationships to Disclose
 
Stefan M. Willems
No Relationships to Disclose
 
Zsuzsanna Varga
No Relationships to Disclose
 
Alicia Cordoba
No Relationships to Disclose
 
Antien L Mooyaart
No Relationships to Disclose
 
Emilie Groen
No Relationships to Disclose
 
Annegien Broeks
No Relationships to Disclose
 
Nikolas Stathonikos
No Relationships to Disclose
 
Katarzyna Józwiak
No Relationships to Disclose
 
Michael Hauptmann
No Relationships to Disclose
 
Gabe S. Sonke
Research Funding - AstraZeneca (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Elsken Van Der Wall
No Relationships to Disclose
 
Sabine Siesling
No Relationships to Disclose
 
Paul J. van Diest
No Relationships to Disclose
 
Sabine C. Linn
Consulting or Advisory Role - AstraZeneca
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - N/A. Patent pending on BRCAness classifier (Inst)
Travel, Accommodations, Expenses - Pfizer; Roche